.FDA turns down psychedelic MDMA-assisted therapy for post-traumatic stress disorder NBC NewsF.D.A. Downtrends to Accept MDMA Treatment, Looking For Even More Research Study The New York TimesFDA Denies Ecstasy-Based Medication The Exchange JournalFDA refuses to permit unfamiliar MDMA treatment to deal with PTSD, with request for even more trial records CNNFDA turns down to begin with psychedelic to manage post-traumatic stress disorder, requiring additional study The Washington Blog post.